These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10618581)

  • 21. The renin-angiotensin system: importance in physiology and pathology.
    Ferrario CM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S1-5. PubMed ID: 1691411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the renin-angiotensin system.
    Cheung BM
    Hong Kong Med J; 2002 Jun; 8(3):185-91. PubMed ID: 12055364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin AT1/AT2 receptors: regulation, signalling and function.
    Kaschina E; Unger T
    Blood Press; 2003; 12(2):70-88. PubMed ID: 12797627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y; Lefebvre J
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG; Scheer C; Rupp H
    J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
    Shim KY; Eom YW; Kim MY; Kang SH; Baik SK
    Korean J Intern Med; 2018 May; 33(3):453-461. PubMed ID: 29462546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological properties of angiotensin II antagonists: examining all the therapeutic implications.
    Unger T
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2 Suppl 2():S4-7. PubMed ID: 11881101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
    Balakumar P; Jagadeesh G
    Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
    Henriksen EJ; Prasannarong M
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin receptors: physiology and pharmacology.
    Guthrie GP
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renin-angiotensin-aldosterone system as a target in coronary disease.
    O'Keefe JH; Lurk JT; Kahatapitiya RC; Haskin JA
    Curr Atheroscler Rep; 2003 Mar; 5(2):124-30. PubMed ID: 12573198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.
    Unger T; Culman J; Gohlke P
    J Hypertens Suppl; 1998 Sep; 16(7):S3-9. PubMed ID: 9855025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells.
    Zhang SL; To C; Chen X; Filep JG; Tang SS; Ingelfinger JR; Carrière S; Chan JS
    Exp Nephrol; 2001; 9(2):109-17. PubMed ID: 11150859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the renin-angiotensin system in cardiovascular disease.
    Cohn JN
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):341-4. PubMed ID: 20454841
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway.
    Rouleau JL; Kapuku G; Pelletier S; Gosselin H; Adam A; Gagnon C; Lambert C; Meloche S
    Circulation; 2001 Aug; 104(8):939-44. PubMed ID: 11514383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting circadian variability.
    Giles TD
    Blood Press Monit; 2000; 5 Suppl 1():S3-7. PubMed ID: 10904236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC; MacDonald TM
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular angiotensin II actions mediated by angiotensin II type 2 receptors.
    Hannan RE; Widdop RE
    Curr Hypertens Rep; 2004 Apr; 6(2):117-23. PubMed ID: 15010015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.
    Regoli D; Gobeil F
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1117-1124. PubMed ID: 28384411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.